关于文章《氢化可的松对重症社区获得性肺炎患者死亡率的影响。REMAP-CAP皮质类固醇领域随机临床试验》的通信 - Suppr

Suppr

超能文献

Correspondence about the article "Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. The REMAP-CAP corticosteroid domain randomized clinical trial".

作者信息

Dequin Pierre-François, Giraudeau Bruno, Le Gouge Amélie

机构信息

INSERM U1100, Center for the Study of Respiratory Diseases, University of Tours, Tours, France.

Médecine Intensive Réanimation, Hôpital Bretonneau, CHU de Tours, Tours, France.

出版信息

Intensive Care Med. 2025 Jul 3. doi: 10.1007/s00134-025-08003-y.

DOI:10.1007/s00134-025-08003-y

PMID:40608083

Abstract

摘要

相似文献

Correspondence about the article "Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. The REMAP-CAP corticosteroid domain randomized clinical trial".

Intensive Care Med. 2025 Jul 3. doi: 10.1007/s00134-025-08003-y.

Correspondence about the article "Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia: the REMAP-CAP corticosteroid domain randomized clinical trial": author's reply.

Intensive Care Med. 2025 Jul 22. doi: 10.1007/s00134-025-08046-1.

Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial.

Intensive Care Med. 2025 Apr;51(4):665-680. doi: 10.1007/s00134-025-07861-w. Epub 2025 Apr 22.

Current corticosteroid therapeutic strategy for community-acquired pneumonia in adults: indications, dosage, and timing.

J Intensive Care. 2025 Jul 1;13(1):37. doi: 10.1186/s40560-025-00809-8.

Efficacy and safety of corticosteroids for the treatment of community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.

J Crit Care. 2024 Apr;80:154507. doi: 10.1016/j.jcrc.2023.154507. Epub 2023 Dec 21.

Corticosteroids for pneumonia.

Cochrane Database Syst Rev. 2017 Dec 13;12(12):CD007720. doi: 10.1002/14651858.CD007720.pub3.

Efficacy of corticosteroid treatment for severe community-acquired pneumonia: A meta-analysis.

Am J Emerg Med. 2018 Feb;36(2):179-184. doi: 10.1016/j.ajem.2017.07.050. Epub 2017 Jul 15.

Corticosteroid therapy for severe community-acquired pneumonia: a meta-analysis.

Respir Care. 2014 Apr;59(4):557-63. doi: 10.4187/respcare.02758. Epub 2013 Sep 17.

[Meta-analysis of hydrocortisone in the treatment of severe community-acquired pneumonia].

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025 Jun;37(6):542-548. doi: 10.3760/cma.j.cn121430-20230710-00500.

Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis.

BMJ Open Respir Res. 2024 Jan 22;11(1):e002141. doi: 10.1136/bmjresp-2023-002141.

本文引用的文献

Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial.

Intensive Care Med. 2025 Apr;51(4):665-680. doi: 10.1007/s00134-025-07861-w. Epub 2025 Apr 22.

Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials.

Lancet Respir Med. 2025 Mar;13(3):221-233. doi: 10.1016/S2213-2600(24)00405-3. Epub 2025 Jan 29.

Hydrocortisone in Severe Community-Acquired Pneumonia.

N Engl J Med. 2023 May 25;388(21):1931-1941. doi: 10.1056/NEJMoa2215145. Epub 2023 Mar 21.

Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death.

J Pain Symptom Manage. 2017 May;53(5):938-943. doi: 10.1016/j.jpainsymman.2016.12.333. Epub 2017 Jan 3.

Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis.

Crit Care. 2008;12(5):R117. doi: 10.1186/cc7011. Epub 2008 Sep 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Correspondence about the article "Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. The REMAP-CAP corticosteroid domain randomized clinical trial".

作者信息

Dequin Pierre-François, Giraudeau Bruno, Le Gouge Amélie

机构信息

INSERM U1100, Center for the Study of Respiratory Diseases, University of Tours, Tours, France.

Médecine Intensive Réanimation, Hôpital Bretonneau, CHU de Tours, Tours, France.

出版信息

Intensive Care Med. 2025 Jul 3. doi: 10.1007/s00134-025-08003-y.

DOI:10.1007/s00134-025-08003-y

PMID:40608083

Abstract

摘要

相似文献

Correspondence about the article "Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. The REMAP-CAP corticosteroid domain randomized clinical trial".

Intensive Care Med. 2025 Jul 3. doi: 10.1007/s00134-025-08003-y.

Intensive Care Med. 2025 Jul 22. doi: 10.1007/s00134-025-08046-1.

Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial.

Intensive Care Med. 2025 Apr;51(4):665-680. doi: 10.1007/s00134-025-07861-w. Epub 2025 Apr 22.

Current corticosteroid therapeutic strategy for community-acquired pneumonia in adults: indications, dosage, and timing.

J Intensive Care. 2025 Jul 1;13(1):37. doi: 10.1186/s40560-025-00809-8.

Efficacy and safety of corticosteroids for the treatment of community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.

J Crit Care. 2024 Apr;80:154507. doi: 10.1016/j.jcrc.2023.154507. Epub 2023 Dec 21.

Corticosteroids for pneumonia.

Cochrane Database Syst Rev. 2017 Dec 13;12(12):CD007720. doi: 10.1002/14651858.CD007720.pub3.

Efficacy of corticosteroid treatment for severe community-acquired pneumonia: A meta-analysis.

Am J Emerg Med. 2018 Feb;36(2):179-184. doi: 10.1016/j.ajem.2017.07.050. Epub 2017 Jul 15.

Corticosteroid therapy for severe community-acquired pneumonia: a meta-analysis.

Respir Care. 2014 Apr;59(4):557-63. doi: 10.4187/respcare.02758. Epub 2013 Sep 17.

[Meta-analysis of hydrocortisone in the treatment of severe community-acquired pneumonia].

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025 Jun;37(6):542-548. doi: 10.3760/cma.j.cn121430-20230710-00500.

Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis.

BMJ Open Respir Res. 2024 Jan 22;11(1):e002141. doi: 10.1136/bmjresp-2023-002141.

本文引用的文献

Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial.

Intensive Care Med. 2025 Apr;51(4):665-680. doi: 10.1007/s00134-025-07861-w. Epub 2025 Apr 22.

Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials.

Lancet Respir Med. 2025 Mar;13(3):221-233. doi: 10.1016/S2213-2600(24)00405-3. Epub 2025 Jan 29.

Hydrocortisone in Severe Community-Acquired Pneumonia.

N Engl J Med. 2023 May 25;388(21):1931-1941. doi: 10.1056/NEJMoa2215145. Epub 2023 Mar 21.

Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death.

J Pain Symptom Manage. 2017 May;53(5):938-943. doi: 10.1016/j.jpainsymman.2016.12.333. Epub 2017 Jan 3.

Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis.

Crit Care. 2008;12(5):R117. doi: 10.1186/cc7011. Epub 2008 Sep 11.